[Skip to Navigation]
Views 252
Citations 0
Comment & Response
July 15, 2020

The Hydrocortisone vs Pasireotide in Reducing Pancreatic Surgery Complications Noninferiority Trial: Comparing Apples and Pears?

Author Affiliations
  • 1Department of Hepatobiliary and Pancreatic Surgery, Nottingham Digestive Diseases Centre and National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Queen’s Medical Centre, Nottingham, England
JAMA Surg. 2020;155(10):994-995. doi:10.1001/jamasurg.2020.1998

To the Editor We read with interest the noninferiority randomized clinical trial (RCT) by Tarvainen et al1 comparing Hydrocortisone vs Pasireotide in Reducing Pancreatic Surgery Complications (HYPAR). Somatostatin analogues have been advocated in the prophylactic setting to reduce the risk of postoperative pancreatic fistula (POPF). Therefore, any trial that was designed to test the noninferiority of a newer treatment against a somatostatin analogue should have been powered on this outcome. Additionally, per protocol analysis that includes all patients who satisfactorily complied with treatment are usually preferred in noninferiority trials because it is more likely to clearly detect any treatment differences. At the very least, this should be reported alongside the intention-to-treat analysis.2

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words